Annual CFI
-$12.45 M
-$12.89 M-2897.53%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual cash flow from investing activities is -$12.45 million, with the most recent change of -$12.89 million (-2897.53%) on December 31, 2023.
- During the last 3 years, MACK annual CFI has fallen by -$14.59 million (-682.00%).
Performance
MACK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$228.00 M
+$227.93 M+335194.12%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly cash flow from investing activities is $228.00 million, with the most recent change of +$227.93 million (+335194.12%) on March 1, 2024.
- Over the past year, MACK quarterly CFI has increased by +$231.84 million (+6029.78%).
Performance
MACK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$215.41 M
+$227.86 M+1830.36%
March 1, 2024
Summary
- As of February 10, 2025, MACK TTM cash flow from investing activities is $215.41 million, with the most recent change of +$227.86 million (+1830.36%) on March 1, 2024.
- Over the past year, MACK TTM CFI has increased by +$227.93 million (+1820.96%).
Performance
MACK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MACK Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2897.5% | +6029.8% | +1821.0% |
| 3 y3 years | -682.0% | +6029.8% | +1821.0% |
| 5 y5 years | +44.9% | +6029.8% | +1821.0% |
MACK Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2897.5% | at low | at high | -103.9% | at high | -105.8% |
| 5 y | 5-year | -117.8% | at low | at high | -103.9% | at high | -105.8% |
| alltime | all time | -102.2% | +504.2% | -60.4% | -137.5% | -66.1% | -135.6% |
Merrimack Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $228.00 M(>+9900.0%) | $215.41 M(-1830.4%) |
| Dec 2023 | -$12.45 M(-2897.5%) | $68.00 K(-101.8%) | -$12.45 M(-0.5%) |
| Sep 2023 | - | -$3.85 M(-56.4%) | -$12.52 M(+44.3%) |
| Jun 2023 | - | -$8.81 M(-6438.8%) | -$8.67 M(-6338.8%) |
| Mar 2023 | - | $139.00 K(>+9900.0%) | $139.00 K(-68.8%) |
| Dec 2022 | $445.00 K(+209.0%) | $0.00(0.0%) | $445.00 K(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $445.00 K(-17.4%) |
| Jun 2022 | - | $0.00(-100.0%) | $539.00 K(0.0%) |
| Mar 2022 | - | $445.00 K(>+9900.0%) | $539.00 K(+274.3%) |
| Dec 2021 | $144.00 K(-93.3%) | $0.00(-100.0%) | $144.00 K(0.0%) |
| Sep 2021 | - | $94.00 K(>+9900.0%) | $144.00 K(+188.0%) |
| Jun 2021 | - | $0.00(-100.0%) | $50.00 K(-119.2%) |
| Mar 2021 | - | $50.00 K(>+9900.0%) | -$261.00 K(-112.2%) |
| Dec 2020 | $2.14 M(-96.9%) | $0.00(0.0%) | $2.14 M(-70.0%) |
| Sep 2020 | - | $0.00(-100.0%) | $7.14 M(-47.7%) |
| Jun 2020 | - | -$311.00 K(-112.7%) | $13.64 M(-67.6%) |
| Mar 2020 | - | $2.45 M(-51.0%) | $42.16 M(-39.6%) |
| Dec 2019 | $69.83 M(-409.0%) | $5.00 M(-23.1%) | $69.83 M(+29.3%) |
| Sep 2019 | - | $6.50 M(-77.0%) | $54.00 M(-26.2%) |
| Jun 2019 | - | $28.21 M(-6.3%) | $73.13 M(+48.2%) |
| Mar 2019 | - | $30.11 M(-378.3%) | $49.35 M(-318.4%) |
| Dec 2018 | -$22.60 M(-103.9%) | -$10.82 M(-142.2%) | -$22.60 M(+261.7%) |
| Sep 2018 | - | $25.62 M(+477.8%) | -$6.25 M(-82.8%) |
| Jun 2018 | - | $4.43 M(-110.6%) | -$36.33 M(-106.8%) |
| Mar 2018 | - | -$41.83 M(-856.8%) | $535.35 M(-7.2%) |
| Dec 2017 | $576.89 M(<-9900.0%) | $5.53 M(-224.1%) | $576.89 M(-1.1%) |
| Sep 2017 | - | -$4.45 M(-100.8%) | $583.08 M(-8.3%) |
| Jun 2017 | - | $576.11 M(<-9900.0%) | $635.87 M(+676.0%) |
| Mar 2017 | - | -$290.00 K(-102.5%) | $81.94 M(-2615.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$3.26 M(-104.3%) | $11.71 M(-75.8%) | -$3.26 M(-76.1%) |
| Sep 2016 | - | $48.34 M(+118.0%) | -$13.63 M(-64.2%) |
| Jun 2016 | - | $22.18 M(-125.9%) | -$38.06 M(+10.8%) |
| Mar 2016 | - | -$85.49 M(-6489.5%) | -$34.34 M(-145.7%) |
| Dec 2015 | $75.11 M(-1349.5%) | $1.34 M(-94.4%) | $75.11 M(+104.8%) |
| Sep 2015 | - | $23.91 M(-7.7%) | $36.68 M(-231.9%) |
| Jun 2015 | - | $25.90 M(+8.1%) | -$27.80 M(+112.0%) |
| Mar 2015 | - | $23.96 M(-164.6%) | -$13.12 M(+118.2%) |
| Dec 2014 | -$6.01 M(-78.3%) | -$37.10 M(-8.6%) | -$6.01 M(-135.3%) |
| Sep 2014 | - | -$40.56 M(-199.9%) | $17.02 M(+160.5%) |
| Jun 2014 | - | $40.59 M(+30.7%) | $6.54 M(-179.9%) |
| Mar 2014 | - | $31.06 M(-320.9%) | -$8.18 M(-70.5%) |
| Dec 2013 | -$27.74 M(-63.1%) | -$14.06 M(-72.5%) | -$27.74 M(-4.5%) |
| Sep 2013 | - | -$51.05 M(-297.3%) | -$29.05 M(-178.6%) |
| Jun 2013 | - | $25.87 M(+124.8%) | $36.97 M(-158.4%) |
| Mar 2013 | - | $11.51 M(-174.9%) | -$63.29 M(-15.9%) |
| Dec 2012 | -$75.22 M(+1907.5%) | -$15.37 M(-202.7%) | -$75.22 M(+23.0%) |
| Sep 2012 | - | $14.97 M(-120.1%) | -$61.14 M(-20.3%) |
| Jun 2012 | - | -$74.39 M(>+9900.0%) | -$76.73 M(+2024.3%) |
| Mar 2012 | - | -$426.00 K(-66.9%) | -$3.61 M(-3.6%) |
| Dec 2011 | -$3.75 M(-23.5%) | -$1.29 M(+104.9%) | -$3.75 M(+26.5%) |
| Sep 2011 | - | -$628.00 K(-50.6%) | -$2.96 M(-33.5%) |
| Jun 2011 | - | -$1.27 M(+126.6%) | -$4.45 M(-12.4%) |
| Mar 2011 | - | -$561.00 K(+11.5%) | -$5.09 M(+3.8%) |
| Dec 2010 | -$4.90 M(+1.0%) | -$503.00 K(-76.3%) | -$4.90 M(+11.4%) |
| Sep 2010 | - | -$2.12 M(+11.4%) | -$4.40 M(+93.0%) |
| Jun 2010 | - | -$1.90 M(+407.5%) | -$2.28 M(+507.5%) |
| Mar 2010 | - | -$375.00 K | -$375.00 K |
| Dec 2009 | -$4.85 M | - | - |
FAQ
- What is Merrimack Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual CFI year-on-year change?
- What is Merrimack Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly CFI year-on-year change?
- What is Merrimack Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals TTM CFI year-on-year change?
What is Merrimack Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of MACK is -$12.45 M
What is the all time high annual CFI for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual cash flow from investing activities is $576.89 M
What is Merrimack Pharmaceuticals annual CFI year-on-year change?
Over the past year, MACK annual cash flow from investing activities has changed by -$12.89 M (-2897.53%)
What is Merrimack Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of MACK is $228.00 M
What is the all time high quarterly CFI for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly cash flow from investing activities is $576.11 M
What is Merrimack Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, MACK quarterly cash flow from investing activities has changed by +$231.84 M (+6029.78%)
What is Merrimack Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of MACK is $215.41 M
What is the all time high TTM CFI for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high TTM cash flow from investing activities is $635.87 M
What is Merrimack Pharmaceuticals TTM CFI year-on-year change?
Over the past year, MACK TTM cash flow from investing activities has changed by +$227.93 M (+1820.96%)